Targeting of chromatin readers: a novel strategy used by the Shigella flexneri virulence effector OspF to reprogram transcription

被引:1
|
作者
Harouz, Habiba [1 ]
Rachez, Christophe [1 ]
Meijer, Benoit [1 ]
Muchardt, Christian [1 ]
Arbibe, Laurence [1 ]
机构
[1] Univ Paris 05, INEM, Dept Immunol Infectiol & Hematol, INSERM U1151,CNRS UMR 8253, Paris, France
来源
MICROBIAL CELL | 2015年 / 2卷 / 01期
关键词
Shigella; OspF; Heterochromatin protein 1; epigenetic; immune gene;
D O I
10.15698/mic2015.01.183
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Shigella flexneri, a gram-negative bacterium responsible of bacillary dysentery, uses multiple strategies to overcome host immune defense. We have decrypted how this bacterium manipulates host-cell chromatin binders to take control of immune gene expression. We found that OspF, an injected virulence factor previously identified as a repressor of immune gene expression, targets the chromatin reader HP1 gamma Heterochromatin Protein 1 family members specifically recognize and bind histone H3 methylated at Lys 9. Although initially identified as chromatin-associated transcriptional silencers in heterochromatin, their location in euchromatin indicates an active role in gene expression. Notably, HP1. phosphorylation at Serine 83 defines a subpopulation exclusively located to euchromatin, targeted to the site of transcriptional elongation. We showed that OspF directly interacts with HP1 gamma and causes HP1 dephosphorylation, suggesting a model in which this virulence effector "uses" HP1 proteins as beacons to target and repress immune gene expression (Harouz, et al. EMBO J (2014)). OspF alters HP1 gamma phosphorylation mainly by inactivating the Erk-activated kinase MSK1, spotlighting it as a new HP1 kinase. In vivo, infectious stresses trigger HP1 gamma phosphorylation in the colon, principally in the lamina propria and the intestinal crypts. Several lines of evidence suggest that HP1 proteins are modified as extensively as histones, and decrypting the impact of these HP1 post-translational modifications on their transcriptional activities in vivo will be the next challenges to be taken up.
引用
收藏
页码:26 / 28
页数:3
相关论文
共 5 条
  • [1] Potential novel antibiotics from HTS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri
    Anthony A Emanuele
    Nancy E Adams
    Yi-Chen Chen
    Anthony T Maurelli
    George A Garcia
    The Journal of Antibiotics, 2014, 67 : 379 - 386
  • [2] Potential novel antibiotics from HIS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri
    Emanuele, Anthony A.
    Adams, Nancy E.
    Chen, Yi-Chen
    Maurelli, Anthony T.
    Garcia, George A.
    JOURNAL OF ANTIBIOTICS, 2014, 67 (05): : 379 - 386
  • [3] TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION IN DIPG
    Ehteda, Anahid
    Simon, Sandy
    Franshaw, Laura
    Giorgi, Federico M.
    Liu, Jie
    Hayden, Elisha
    Rouaen, Jourdin
    Pang, Chi Nam Ignatius
    Pandher, Ruby
    Mayoh, Chelsea
    Tang, Yujie
    Khan, Aaminah
    Ung, Caitlin
    Kankean, Anne
    Lehmann, Rebecca
    Shen, Sylvie
    Gopalakrishnan, Anjana
    Trebilcock, Peter
    Gurova, Katerina
    Gudkov, Andrei
    Norris, Murray D.
    Haber, Michelle
    Vittorio, Orazio
    Tsoli, Maria
    Ziegler, David S.
    NEURO-ONCOLOGY, 2021, 23 : 18 - 19
  • [4] TARGETING THE HEDGEHOG PATHWAY TRANSCRIPTION EFFECTOR Gli2 IS A NOVEL THERAPEUTIC STRATEGY FOR SEVERE SCHISTOSOMIASIS MANSONI FIBROSIS AND PORTAL HYPERTENSION
    Pereira, Thiago De Almeida
    Vidigal, Paula
    Diehl, Anna Mae
    Wynn, Thomas
    Beachy, Philip
    HEPATOLOGY, 2023, 78 : S1547 - S1548
  • [5] TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION
    Ehteda, Anahid
    Franshaw, Laura
    Liu, Jie
    Joshi, Swapna
    Simon, Sandy
    Pang, Chi Nam Ignatius
    Giorgi, Federico
    Pandher, Ruby
    Ung, Caitlin
    Tolhurst, Ornella
    Mayoh, Chelsea
    Khan, Aaminah
    Hayden, Elisha
    Gopalakrishnan, Anjana
    Trebilcock, Peter
    Upton, Dannielle
    Lehmann, Rebecca
    George, Sandra
    Vittorio, Orazio
    Tsoli, Maria
    Gurova, Katerina
    Gudkov, Andrei Gudkov
    Norris, Murray D.
    Haber, Michelle
    Ziegler, David S.
    NEURO-ONCOLOGY, 2020, 22 : 292 - 292